View in EDS

TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.

Saved in:
Bibliographic Details
Title: TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Authors: Thiel KW; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA., Devor EJ; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA., Filiaci VL; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Mutch D; Washington University School of Medicine, Siteman Cancer Center, St Louis, MO., Moxley K; Stephenson Cancer Center, Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK., Alvarez Secord A; Duke University Institute, Duke University Health System, Durham, NC., Tewari KS; University of California Irvine Medical Center, Irvine, CA., McDonald ME; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA., Mathews C; Women and Infants Hospital in Rhode Island/The Warren Alpert Medical School of Brown University, Providence, RI., Cosgrove C; Ohio State University Medical Center, James Cancer Hospital and Solove Research Institute, Obstetrics and Gynecology, Columbus, OH., Dewdney S; Rush University Medical Center, Gynecology, Chicago, IL., Aghajanian C; Memorial Sloan Kettering Cancer and Weill Cornell Medical Center, New York, NY., Samuelson MI; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA., Lankes HA; Biopathology Center, The Research Institute at Nationwide Children's Hospital, Columbus, OH., Soslow RA; The University of New Mexico Health Sciences Center, Albuquerque, NM., Leslie KK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.; The University of New Mexico Health Sciences Center, Albuquerque, NM.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Oct 01; Vol. 40 (28), pp. 3289-3300. Date of Electronic Publication: 2022 Jun 03.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, American Recovery and Reinvestment Act; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35658479
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Thiel+KW%22">Thiel KW</searchLink>; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.<br /><searchLink fieldCode="AU" term="%22Devor+EJ%22">Devor EJ</searchLink>; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.<br /><searchLink fieldCode="AU" term="%22Filiaci+VL%22">Filiaci VL</searchLink>; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY.<br /><searchLink fieldCode="AU" term="%22Mutch+D%22">Mutch D</searchLink>; Washington University School of Medicine, Siteman Cancer Center, St Louis, MO.<br /><searchLink fieldCode="AU" term="%22Moxley+K%22">Moxley K</searchLink>; Stephenson Cancer Center, Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK.<br /><searchLink fieldCode="AU" term="%22Alvarez+Secord+A%22">Alvarez Secord A</searchLink>; Duke University Institute, Duke University Health System, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Tewari+KS%22">Tewari KS</searchLink>; University of California Irvine Medical Center, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22McDonald+ME%22">McDonald ME</searchLink>; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.<br /><searchLink fieldCode="AU" term="%22Mathews+C%22">Mathews C</searchLink>; Women and Infants Hospital in Rhode Island/The Warren Alpert Medical School of Brown University, Providence, RI.<br /><searchLink fieldCode="AU" term="%22Cosgrove+C%22">Cosgrove C</searchLink>; Ohio State University Medical Center, James Cancer Hospital and Solove Research Institute, Obstetrics and Gynecology, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Dewdney+S%22">Dewdney S</searchLink>; Rush University Medical Center, Gynecology, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Aghajanian+C%22">Aghajanian C</searchLink>; Memorial Sloan Kettering Cancer and Weill Cornell Medical Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Samuelson+MI%22">Samuelson MI</searchLink>; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.<br /><searchLink fieldCode="AU" term="%22Lankes+HA%22">Lankes HA</searchLink>; Biopathology Center, The Research Institute at Nationwide Children's Hospital, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Soslow+RA%22">Soslow RA</searchLink>; The University of New Mexico Health Sciences Center, Albuquerque, NM.<br /><searchLink fieldCode="AU" term="%22Leslie+KK%22">Leslie KK</searchLink>; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.; The University of New Mexico Health Sciences Center, Albuquerque, NM.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2022 Oct 01; Vol. 40 (28), pp. 3289-3300. <i>Date of Electronic Publication: </i>2022 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, American Recovery and Reinvestment Act; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35658479
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.21.02506
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3289
    Titles:
      – TitleFull: TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Thiel KW
      – PersonEntity:
          Name:
            NameFull: Devor EJ
      – PersonEntity:
          Name:
            NameFull: Filiaci VL
      – PersonEntity:
          Name:
            NameFull: Mutch D
      – PersonEntity:
          Name:
            NameFull: Moxley K
      – PersonEntity:
          Name:
            NameFull: Alvarez Secord A
      – PersonEntity:
          Name:
            NameFull: Tewari KS
      – PersonEntity:
          Name:
            NameFull: McDonald ME
      – PersonEntity:
          Name:
            NameFull: Mathews C
      – PersonEntity:
          Name:
            NameFull: Cosgrove C
      – PersonEntity:
          Name:
            NameFull: Dewdney S
      – PersonEntity:
          Name:
            NameFull: Aghajanian C
      – PersonEntity:
          Name:
            NameFull: Samuelson MI
      – PersonEntity:
          Name:
            NameFull: Lankes HA
      – PersonEntity:
          Name:
            NameFull: Soslow RA
      – PersonEntity:
          Name:
            NameFull: Leslie KK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 28
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1